AI assistant
GERON CORP — Director's Dealing 2022
Jul 12, 2022
32370_dirs_2022-07-12_68d88ba2-208a-4528-aed6-89b520b29221.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2022-07-09
Reporting Person: Feller Faye (EVP, Chief Medical Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (right to buy) | $1.740 | 2029-04-16 | Common Stock (400000) | Direct | |
| Stock Options (right to buy) | $1.740 | 2029-04-16 | Common Stock (80000) | Direct | |
| Stock Options (right to buy) | $1.295 | 2030-02-11 | Common Stock (155400) | Direct | |
| Stock Options (right to buy) | $2.055 | 2031-02-01 | Common Stock (155400) | Direct | |
| Stock Options (right to buy) | $1.060 | 2032-02-15 | Common Stock (200000) | Direct |
Footnotes
F1: This option vests as follows: 50,000 shares on October 8, 2019, the remaining 350,000 shares in a series of 42 equal monthly installments commencing October 8, 2019, provided the optionee continues to provide services to the Company.
F2: This option vests in 3 years on April 8, 2022, provided the optionee continues to provide services to the Company.
F3: This option vests in a series of 48 consecutive equal monthly installments commencing on February 12, 2020, provided the optionee continues to provide services to the Company.
F4: This option vests in a series of 48 consecutive equal monthly installments commencing on February 2, 2021, provided the optionee continues to provide services to the Company.
F5: This option vests in a series of 48 consecutive equal monthly installments commencing on February 16, 2022, provided the optionee continues to provide services to the Company.